Fig. 1.
Fig. 1. Anti-CD40L mAb alone or in combination with (A) sirolimus or (B) CsA results in long-term multilineage engraftment. / Mice from Table 1 were phenotyped at 3.5 months after BMT for donor-host origin of CD4+ and CD8+ T cells, CD19+ B cells and MAC-1+ myeloid cells. On the y-axis are shown the host and donor proportions of each of the lineages. The solid part of the bar indicates the proportion of each lineage that is of host origin; the striped part of the bar indicates the proportion of each lineage that is of donor origin. Irrelevant hIgG-treated mice had no detectable donor chimerism and thus are composed entirely of host-type cells. * Indicates P < .05 compared with donor proportion in mice receiving anti-CD40L mAb as a single agent.

Anti-CD40L mAb alone or in combination with (A) sirolimus or (B) CsA results in long-term multilineage engraftment.

Mice from Table 1 were phenotyped at 3.5 months after BMT for donor-host origin of CD4+ and CD8+ T cells, CD19+ B cells and MAC-1+ myeloid cells. On the y-axis are shown the host and donor proportions of each of the lineages. The solid part of the bar indicates the proportion of each lineage that is of host origin; the striped part of the bar indicates the proportion of each lineage that is of donor origin. Irrelevant hIgG-treated mice had no detectable donor chimerism and thus are composed entirely of host-type cells. * Indicates P < .05 compared with donor proportion in mice receiving anti-CD40L mAb as a single agent.

Close Modal

or Create an Account

Close Modal
Close Modal